These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 8999136)

  • 21. [View of development of fluoroquinolones].
    Namba K
    Kekkaku; 1999 Jan; 74(1):47-52. PubMed ID: 10067055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anti-Mycobacterium avium complex activities of KRM-1648, clarithromycin and levofloxacin in 7HSF medium at peak or average blood concentrations after their oral administration of clinical dosages].
    Sato K; Akaki T; Tomioka H
    Kekkaku; 1997 Jul; 72(7):449-53. PubMed ID: 9259129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New agents active against Mycobacterium avium complex selected by molecular topology: a virtual screening method.
    García-García A; Gálvez J; de Julián-Ortiz JV; García-Domenech R; Muñoz C; Guna R; Borrás R
    J Antimicrob Chemother; 2004 Jan; 53(1):65-73. PubMed ID: 14645324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Maxaquin in the combined treatment of tuberculosis].
    Sokolova GB; Mozhokina GN; Kunichan AD; Elistratova NA; Perel'man MI
    Probl Tuberk; 2000; (5):35-9. PubMed ID: 11077850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The bacteriology of tuberculosis and non-tuberculosis mycobacterial infections].
    Wyplosz B; Truffot-Pernot C; Robert J; Jarlier V; Grosset J
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S33-48. PubMed ID: 9496590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electron microscopic analysis of Mycobacterium avium complex isolates exposed to ciprofloxacin, rifabutin, ethambutol and clarithromycin.
    Reisner BS; Woods GL; Popov VL
    Int J Tuberc Lung Dis; 1997 Jun; 1(3):270-5. PubMed ID: 9432376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical evaluation of new quinolones as antituberculosis drugs].
    Kawahara S; Tada A; Nagare H
    Kekkaku; 1999 Jan; 74(1):71-5. PubMed ID: 10067058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
    Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
    J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The place of quinolones in medicine today.
    Oh HM
    Singapore Med J; 1994 Dec; 35(6):562-4. PubMed ID: 7761876
    [No Abstract]   [Full Text] [Related]  

  • 31. Prediction of quinolone activity against Mycobacterium avium by molecular topology and virtual computational screening.
    Gozalbes R; Brun-Pascaud M; García-Domenech R; Gálvez J; Girard PM; Doucet JP; Derouin F
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2764-70. PubMed ID: 10991858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The pattern of development of resistance to antituberculosis agents in mycobacterium avium complex].
    Tsukamura M
    Kekkaku; 1987 Sep; 62(9):445-58. PubMed ID: 3430947
    [No Abstract]   [Full Text] [Related]  

  • 33. In-vitro activity of lomefloxacin against pathogenic and environmental mycobacteria.
    Banerjee DK; Ford J; Markanday S
    J Antimicrob Chemother; 1992 Aug; 30(2):236-8. PubMed ID: 1328136
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of Tween 80 on the growth of Mycobacterium avium complex.
    Masaki S; Sugimori G; Okamoto A; Imose J; Hayashi Y
    Microbiol Immunol; 1990; 34(8):653-63. PubMed ID: 2280723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sparfloxacin].
    Enferm Infecc Microbiol Clin; 1998 Jan; 16(1):49-50. PubMed ID: 9542316
    [No Abstract]   [Full Text] [Related]  

  • 36. [Current and future aspects of quinolones].
    Bush V; Dalkhoff A; Tsaĭler KhI
    Antibiot Khimioter; 1993; 38(2-3):3-8. PubMed ID: 8074561
    [No Abstract]   [Full Text] [Related]  

  • 37. Action of clofazimine on the Mycobacterium avium complex.
    Warek U; Falkinham JO
    Res Microbiol; 1996; 147(1-2):43-8. PubMed ID: 8761721
    [No Abstract]   [Full Text] [Related]  

  • 38. Quinolones and serum butyryl-cholinesterase activity.
    Paradelis AG; Tzouveleki M; Kouvelas D; Salpigides G; Pangalis A; Crassaris LG
    J Chemother; 1995 Nov; 7 Suppl 4():34-5. PubMed ID: 8904098
    [No Abstract]   [Full Text] [Related]  

  • 39. [In vitro activity of antituberculous agents in relation to ventilation in culture medium].
    Okamoto S; Kanai K; Murohashi T
    Kekkaku; 1965 Dec; 38(13):551-5. PubMed ID: 5883255
    [No Abstract]   [Full Text] [Related]  

  • 40. [In vitro study of the antibacterial effect of streptomycin-L-glutamate].
    Gyarmati I; Jólesz F
    Fogorv Sz; 1971 Dec; 64(12):445-6. PubMed ID: 5290841
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.